Mastodawn

#science #medicine #health #cancer #immunotherapy
https://www.bbc.co.uk/future/article/20260410-how-a-new-wave-of-immunotherapy-is-eliminating-cancers

'It's incredible, like science fiction': How a new wave of immunotherapy is eliminating cancers

After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – and saving patients' lives.

BBC

NewsletterTF 4d ago

Vitale Faces Fifth Cancer Battle: Melanoma in Lung, Liver

Dick Vitale, 86, announced on April 14, 2026, he has melanoma in his lung and liver. He will start immunotherapy soon. This is his fifth cancer fight.

#DickVitale, #CancerBattle, #Melanoma, #ESPN, #Immunotherapy

https://newsletter.tf/dick-vitale-5th-cancer-melanoma-lung-liver-april-14/

NewsletterTF 4d ago

Dick Vitale faces his fifth cancer battle. Melanoma has been found in his lung and liver, and he will begin immunotherapy. This comes after he was declared cancer-free in summer 2025.

#DickVitale, #CancerBattle, #Melanoma, #ESPN, #Immunotherapy
https://newsletter.tf/dick-vitale-5th-cancer-melanoma-lung-liver-april-14/

Dick Vitale's 5th Cancer Battle: Melanoma Found in Lung and Liver on April 14, 2026

Dick Vitale, 86, announced on April 14, 2026, he has melanoma in his lung and liver. He will start immunotherapy soon. This is his fifth cancer fight.

NewsletterTF

Emily Hermann 5d ago

19 rounds of treatment down (IT & IV chemo, IV immuno), 7 to go (not including oral chemo because that’s too much to count.)

That bell is mine in September!

#cancer #leukemia #chemo #BCellALL #hope #cure #AYA #youngadultcancer #maternalcancer #awareness #AYAcancer #bloodcancer #faith #optimism #hopecore #oncology #hospital #medical #immunotherapy #mentalhealth #HealthyCoping #support #chronicillness #cancerawareness #cancerwarrior #LeukemiaAwareness #all

KillBait News Apr 11

Zeaxanthin May Enhance Immunotherapy by Strengthening T Cells

📰 Original title: A common nutrient could supercharge cancer treatment

🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅

View full AI summary: https://killbait.com/en/zeaxanthin-may-enhance-immunotherapy-by-strengthening-t-cells/?redirpost=20f06c86-ef6e-4e93-94a1-52e5693c34db

#science #zeaxanthin #immunotherapy #cancer

KillBait Apr 11

Zeaxanthin May Enhance Immunotherapy by Strengthening T Cells

📰 Original title: A common nutrient could supercharge cancer treatment

🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅

View full AI summary: https://killbait.com/en/zeaxanthin-may-enhance-immunotherapy-by-strengthening-t-cells/?redirpost=20f06c86-ef6e-4e93-94a1-52e5693c34db

#science #zeaxanthin #immunotherapy #cancer

Zeaxanthin May Enhance Immunotherapy by Strengthening T Cells

Researchers at the University of Chicago Medical Center have discovered that zeaxanthin—a carotenoid commonly found in vegetables such as orange peppers, spinach, and kale and known for supporting eye…

KillBait Archive

MedBridgeNZ Apr 8

Is the cost of immunotherapy out of reach?

China’s PD-1 treatments (Toripalimab/Sintilimab) offer 70-85% savings vs. Western prices—often starting at just $1,500/cycle.

As a leading medical concierge provider, MedBridgeNZ facilitates seamless access to Medical Tourism China for oncology patients worldwide.

Expert matching
"Fapiao" insurance claim support
End-to-end logistics

Read our 2026 Cost & Hospital Guide: https://zurl.co/2kZr0

#Immunotherapy #Oncology #ChinaMedicalTourism

China PD-1 Immunotherapy Cost & Hospital Guide: An Objective Choice

Key Takeaways • Significant Cost Efficiency: The estimated out-of-pocket cost for a single cycle of PD-1 immunotherapy at top-tier public hospitals in China ranges from $1,500 to $3,000 USD, representing a 70% to 85% financial reduction compared to Western healthcare systems. • Ethnic Specificity and Clinical Efficacy: Clinical data indicates that regimens such as Toripalimab and Sintilimab demonstrate meaningful overall survival (OS) improvements in Asian populations with specific genomic profi

Medbridge Nz

Howard Smith MD, AM Apr 8

Empowering Ovarian Cancer Immunotherapy. Aggressive ovarian cancers are deadly because they block a patient’s immune system. A new study demonstrates how this shield can be removed. #OvarianCancer #CancerResearch #Immunotherapy #MedicalBreakthrough #FutureMedicine
https://www.instagram.com/p/DW4hROxj-EJ/

Howard G. Smith MD, AM on Instagram: "Empowering Ovarian Cancer Immunotherapy Aggressive ovarian cancers are deadly in part because they block a patient’s immune system from recognizing the tumor. This is why immunotherapy frequently fails. A new study suggests scientists may have found a way to remove that shield. UC-San Diego oncologists discover that many ovarian tumors produce high levels of a protein called FAK, focal adhesion kinase, which helps cancer cells hide from immune killer cells. When the researchers block FAK protein production and add chemotherapy in animal studies, an important synergy develops: • More immune T cells and B cells converge on the tumor. • Tumor growth slows. • Survival improves. Even more interesting, blocking FAK reprograms immune macrophages so they begin sending signals that recruit other immune cells to attack the tumor. The bottom line: if randomized clinical studies confirm that combining effective chemotherapy with FAK inhibitors that energize immunotherapy creates a more powerful strategy against advanced ovarian cancer, we could see more women successfully fighting this deadly cancer….someday soon. #OvarianCancer #CancerResearch #Immunotherapy #MedicalBreakthrough #FutureMedicine"

0 likes, 0 comments - drhowardsmithreports on April 8, 2026: "Empowering Ovarian Cancer Immunotherapy Aggressive ovarian cancers are deadly in part because they block a patient’s immune system from recognizing the tumor. This is why immunotherapy frequently fails. A new study suggests scientists may have found a way to remove that shield. UC-San Diego oncologists discover that many ovarian tumors produce high levels of a protein called FAK, focal adhesion kinase, which helps cancer cells hide from immune killer cells. When the researchers block FAK protein production and add chemotherapy in animal studies, an important synergy develops: • More immune T cells and B cells converge on the tumor. • Tumor growth slows. • Survival improves. Even more interesting, blocking FAK reprograms immune macrophages so they begin sending signals that recruit other immune cells to attack the tumor. The bottom line: if randomized clinical studies confirm that combining effective chemotherapy with FAK inhibitors that energize immunotherapy creates a more powerful strategy against advanced ovarian cancer, we could see more women successfully fighting this deadly cancer….someday soon. #OvarianCancer #CancerResearch #Immunotherapy #MedicalBreakthrough #FutureMedicine".

Instagram